Accelerate Diagnostics Inc
NASDAQ:AXDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Accelerate Diagnostics Inc
NASDAQ:AXDX
|
US |
|
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
|
IN |
|
S
|
SFD SA
WSE:SFD
|
PL |
|
D
|
Dowlais Group Plc
LSE:DWL
|
UK |
|
A
|
AXA SA
MIL:AXA
|
FR |
|
A
|
Amazon.com Inc
XMUN:AMZ
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AXDX's stock price target?
Not Available
AXDX does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Accelerate Diagnostics Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 1 year is 7%.